Wednesday, August 6, 2025

Adenomyosis: A Common Yet Overlooked Cause of Heavy and Painful Periods

 


 

For many women, menstrual periods are uncomfortable—but for some, they are debilitating. If you suffer from unusually heavy menstrual bleeding (also known as menorrhagia) or painful periods, you may have been told it's “normal” or simply a part of womanhood. However, such symptoms could be signs of an often-misunderstood condition known as adenomyosis.

 Dr. Steven R. Goldstein, a top gynecologist in Manhattan and a nationally recognized expert in gynecologic imaging, urges women not to ignore these symptoms. With over 25 years of clinical experience and a professorship at the New York University School of Medicine, Dr. Goldstein specializes in diagnosing conditions like adenomyosis using advanced, non-invasive techniques. If you are suffering from heavy or painful menstruation, timely and accurate diagnosis can dramatically improve your quality of life.

 What Is Adenomyosis?

 Adenomyosis is a benign (non-cancerous) but often painful gynecologic condition in which the inner lining of the uterus (endometrium) breaks through into the muscle wall of the uterus (myometrium). This displaced tissue continues to behave as it normally would during your monthly cycle—thickening, breaking down, and bleeding. But because the blood becomes trapped within the uterine wall, it causes swelling, inflammation, and intense discomfort.

 The result? Heavy periods, prolonged bleeding, and severe cramping—often mistaken for other common conditions such as uterine fibroids. Unlike fibroids, which are distinct growths, adenomyosis causes a more diffuse thickening of the uterine walls, often making the uterus feel enlarged and tender.

 Symptoms of Adenomyosis

 Every woman experiences adenomyosis differently, but common symptoms include:

 Heavy or prolonged menstrual bleeding

  • Severe menstrual cramps
  • A feeling of pelvic pressure or fullness
  • Pain during intercourse
  • An enlarged, tender uterus (often detected during a pelvic exam

     
    If these symptoms sound familiar, it’s time to see a gynecologist with expertise in evaluating complex bleeding disorders.

 

Why Diagnosis Matters

 Too often, adenomyosis is misdiagnosed—or missed entirely. Some women are told their symptoms are due to fibroids, hormonal imbalance, or even early menopause. Accurate diagnosis is critical, not only to relieve symptoms but also to avoid unnecessary or invasive treatments that may not address the true cause of your discomfort.

Dr. Goldstein, an obgyn in Manhattan, cautions that not all bleeding is due to a menstrual period, even if it appears to occur monthly. A true period is defined as bleeding that happens approximately 14 days after ovulation. Any bleeding outside this pattern, especially if it is heavy or painful, deserves further evaluation.

 Advanced, Non-Invasive Diagnosis with Dr. Steven R. Goldstein

 One of the distinguishing features of Dr. Goldstein’s practice is his commitment to using non-invasive, high-resolution imaging to evaluate patients. He is globally recognized as a leading specialist in transvaginal ultrasound, a safe and comfortable method for visualizing the uterus and surrounding structures.

 With transvaginal ultrasound, Dr. Goldstein is able to detect

 

  • Displaced endometrial tissue
  • Changes in the uterine wall consistent with adenomyosis
  • Enlargement of the uterus
  • Other potential causes of abnormal bleeding

 

In addition to transvaginal ultrasound, Dr. Goldstein also performs sonohysterography, a procedure in which a sterile saline solution is gently introduced into the uterus during ultrasound imaging. This technique provides even clearer images of the uterine cavity and walls, allowing for a highly accurate diagnosis. Importantly, both procedures are non-invasive, painless, and done right in the office—without the need for sedation or surgery.

 Compassionate, Expert Care

 Dr. Goldstein personally performs all ultrasounds and sonohysterograms, ensuring that each patient receives the benefit of his expertise from start to finish. His goal is to identify the precise cause of your symptoms without resorting to painful procedures like endometrial biopsies unless absolutely necessary.

 Too many women suffer in silence or undergo unnecessary treatments without ever receiving a correct diagnosis. If you are dealing with persistent heavy bleeding or painful periods, you deserve answers—and relief.

 Schedule a Consultation

 If you suspect you may have adenomyosis or are experiencing unexplained heavy or painful periods, Dr. Steven R. Goldstein, a gynecologist in Manhattan, offers comprehensive, compassionate care in the heart of New York City. As a former Director of Gynecologic Ultrasound at NYU Langone Medical Center and a professor at NYU, he brings both world-class expertise and personal attention to every patient interaction.

 

Tuesday, August 5, 2025

Addressing Vaginal Atrophy in Menopausal Women

 

 


Dr Steven R Goldstein MD is a  menopause specialist in NYC. He was awarded the Thomas A Clarkson award for his many outstanding contributions to menopause related clinical or basic science research and is a Past President of both The Menopause Society and the International Menopause Society. He is a Certified Menopause Practitioner.

Menopause marks a significant transition in a woman’s life, often accompanied by a range of physical and emotional changes. Among these, the decline in estrogen production is a defining biological event. This hormonal shift leads to a variety of physiological changes, one of the most impactful being vaginal atrophy. Despite its prevalence and the significant effect it can have on quality of life, vaginal atrophy remains a largely under-discussed condition, with many women unaware that effective, safe treatments exist.

When estrogen production ceases during menopause, the vaginal tissues undergo substantial alterations. The vagina becomes atrophic—it loses its blood supply and elasticity, and its natural pH balance is disrupted. These changes result in a thinning and drying of the vaginal walls, leading to symptoms such as discomfort, itching, and most notably, painful intercourse.

This condition, known clinically as genitourinary syndrome of menopause (GSM), is not merely a natural consequence of aging but a medical condition with clear underlying causes and viable treatment options.

Unfortunately, societal stigma and lack of education contribute to a widespread silence surrounding these symptoms. Recent studies have revealed that up to 50% of postmenopausal women are unaware that treatments for vaginal atrophy are available and safe. Many women mistakenly accept these symptoms as an inevitable part of aging. As a result, they suffer in silence, often experiencing a diminished quality of life and strain in intimate relationships. The misconception that nothing can be done prevents them from seeking help, and their concerns remain unaddressed.

Dr. Goldstein, a leading menopause specialist NYC, emphasizes the importance of maintaining sexual intimacy in partnered relationships. According to him, sexual health is an integral part of overall well-being, and vaginal atrophy should not be a barrier to intimacy or personal comfort. Importantly, there are several evidence-based treatment options available that can effectively manage the symptoms of vaginal atrophy, many of which have been in use for years and are well-tolerated.

Among the most commonly prescribed therapies are low-dose estrogen treatments, which come in various forms including creams, tablets, and vaginal rings. These treatments work by delivering a small amount of estrogen directly to the vaginal tissues, restoring moisture, elasticity, and normal pH levels without significantly affecting systemic hormone levels. As a result, they offer targeted relief with minimal risk, especially for women who may have concerns about hormone therapy.

In addition to traditional estrogen therapies, there are newer, non-estrogen alternatives. One such option is an oral medication that has shown promise not only in treating vaginal atrophy but also in potentially supporting bone and breast health—an important consideration for postmenopausal women. Another innovative approach involves the use of DHEA (dehydroepiandrosterone) in the form of a local vaginal insert. While DHEA is not classified as a hormone therapy, it is metabolized within the vaginal tissues to produce both estrogen and testosterone, offering symptom relief without systemic hormonal exposure.

The availability of multiple treatment options means that women can work with their healthcare providers to find a solution tailored to their individual needs and medical history. However, the first and most critical step is awareness. Healthcare professionals must take a proactive role in discussing vaginal health with menopausal patients. Likewise, public health campaigns and educational resources should strive to destigmatize this topic and empower women with information.

In conclusion, vaginal atrophy is a common but treatable condition that affects many women during and after menopause. The silence and misconceptions surrounding this issue only serve to exacerbate the suffering of those affected. By fostering open conversations, promoting awareness, and encouraging access to safe and effective treatments, we can help ensure that no woman has to endure these symptoms alone. Menopause is a natural stage of life, but living with untreated vaginal atrophy does not have to be.

Women who are experiencing vagina atrophy or painful intercourse, may schedule an appointment with Dr Goldstein a leading hormone specialist NYC .